New study shows Hyperbaric Oxygen Therapy (HBOT) improves heart function and cardiac performance

New study shows Hyperbaric Oxygen Therapy (HBOT) improves heart function and cardiac performance


This study looked at the performance of the heart as they followed 31 patients, each undergoing a course of 60 hyperabric sessions with the goal of improving cognitive performance. Of these 31 patients, 39% were diagnosed with heart disease, 94% suffered from high blood pressure, and 42% had diabetes mellitus. Most importantly, all 31 patients were screened to be asymptomatic, and did not have any symptoms of heart disease (representing the majority of the public). Researchers documented their results by using pre- and post-imaging of the heart through ultrasound (echocardiogram). The results were extremely favorable following the addition of 60 hyperbaric sessions; ejection fraction (EF) of the heart improved, left ventricular and systolic volume decreased. Myocardial performance index [Mpi] improved, left ventricular [LV] global longitudinal strain increased, and apical rotation improved. This study gives hope for those individuals suffering from heart failure and systolic dysfunction and who need to improve their cardiac performance.
Source: Hyperbaric Experts


Hyperbaric oxygenation therapy is successfully implemented for the treatment of several disorders. Data on the effect of hyperbaric oxygenation on echocardiographic parameters in asymptomatic patients is limited. The current study sought to evaluate the effect of hyperbaric oxygenation therapy on echocardiographic parameters in asymptomatic patients. Thirty-one consecutive patients underwent a 60-sessions course of hyperbaric oxygenation therapy in an attempt to improve cognitive impairment. In all subjects, echocardiography examination was performed before and after a course of hyperbaric oxygenation therapy. Conventional and speckle tracking imaging parameters were calculated and analyzed. The mean age was 70?±?9.5 years, 28 [90%] were males. History of coronary artery disease was present in 12 [39%]. 94% suffered from hypertension, 42% had diabetes mellitus. Baseline wall motion abnormalities were found in eight patients, however, global ejection fraction was within normal limits. During the study, ejection fraction [EF], increased from 60.71?±?6.02 to 62.29?±?5.19%, p?=?0.02. Left ventricular end systolic volume [LVESV], decreased from 38.08?±?13.30 to 35.39?±?13.32 ml, p?=?0.01. Myocardial performance index [MPi] improved, from 0.29?±?0.07 to 0.26?±?0.08, p?=?0.03. Left ventricular [LV] global longitudinal strain increased from -?19.31?±?3.17% to -?20.16?±?3.34%, p?=?0.036 due to improvement in regional strain in the apical and antero-septal segments. Twist increased from 18.32?±?6.61° to 23.12?±?6.35° p?=?0.01, due to improvement in the apical rotation, from 11.76?±?4.40° to 16.10?±?5.56°, p?=?0.004. Hyperbaric oxygen therapy appears to improve left ventricular function, especially in the apical segments, and is associated with better cardiac performance. If our results are confirmed in further studies, HBOT can be used in many patients with heart failure and systolic dysfunction.

Source: Int J Cardiovasc Imaging, 2020 Jan 17
See: PubMed

Leave a Reply